openPR Logo
Press release

Yaz Lawsuit Settlements Reach $142 Million

04-30-2012 01:12 PM CET | Politics, Law & Society

Press release from: Nadrich & Cohen LLP

Nadrich & Cohen, LLP reports that Bayer is continuing to offer settlements to plaintiffs involved in federal Yaz side effects litigation.

Los Angeles, CA, April 27, 2012 – Nadrich & Cohen, LLP reports that German drug-maker Bayer AG has settled approximately 651 Yaz side effects lawsuits totaling $142 million. Earlier this month, it was reported that the drug-maker had reached settlements in approximately 500 cases filed by women who claimed that they suffered serious complications after using Yaz birth control pills.

According to a Bloomberg report, the settlements average out to approximately $218,000 per plaintiff and more settlements are expected to be forthcoming. Prior to Bayer’s latest announcement, JPMorgan Chase & Co. analyst Richard Vosser said that the Yaz lawsuit settlements may end up costing Bayer an estimated $2.65 billion. Yaz is believed to be linked to numerous reports of serious complications, including deep vein thrombosis, pulmonary embolism, heart attack and stroke.

News of additional settlements in the Yaz side effects litigation comes just after the U.S. Food and Drug Administration announced it would require Bayer to issue updated warning labels for Yaz, Yasmin and several other oral contraceptives made by the company. Specifically, the new warning labels will advise women that using birth control pills containing a synthetic hormone known as drospirenone, the primary ingredient in Yaz, may result in a threefold risk of experiencing a serious blood clot.

An FDA advisory panel was convened in December 2011 following the publication of an FDA-funded research study in 2011 which indicated that women who used Yaz may be up to 74% more likely to experience a blood clot compared to women who used older types of birth control pills. While the panel eventually voted 15-11 to allow the continued sale of Yaz, its members agreed that stronger warning labels for the drug were necessary.

Currently, there are thousands of Yaz lawsuits still pending against Bayer in the U.S. A number of these lawsuits have been consolidated into a federal multidistrict litigation (MDL), which is being heard in an Illinois court. The first trials in the Yaz litigation were scheduled to begin in January, but the judge presiding over the cases ordered both sides to mediation instead. Bellwether trials are set to begin at the end of this month if the mediation talks prove ineffective.

Women who believe they suffered a stroke, blood clot or other injury caused by Yaz are encouraged to complete a MedWatch form by visiting the FDA’s website. Injury victims are also urged to contact an experienced Yaz birth control injury lawyer to discuss their legal rights.

Nadrich & Cohen LLP offers confidential, no-cost consultations to Yaz users who believe they were harmed by the drug. Help is available by calling the firm’s injury hotline at 1-800-722-0765 or by completing an online case evaluation form at www.yazbirthcontrolinjury.com.

Nadrich & Cohen LLP is a national law firm with offices in Los Angeles, Sacramento, San Diego and other cities throughout California. The firm specializes in handling mass tort actions and representing individuals in cases involving pharmaceutical companies, medical device makers and other product manufacturers. The firm is committed to achieving the best outcome possible in every case and has recovered over $200 million in settlements on behalf of its clients.

In addition to handling Yaz side effects claims, Nadrich & Cohen, LLP is currently investigating cases involving Actos, DePuy Hip Implants, Zimmer Hips, Wright Conserve Hips, Vaginal Mesh, Pradaxa, Reflex Sympathy Dystrophy, Fen Phen and PPH, Depakote and Reglan. All cases are accepted on a contingency basis, meaning there is never a fee unless a judgment is recovered on your behalf.

Jennifer Poole
National Client Intake Coordinator
Nadrich & Cohen LLP
12100 Wilshire Blvd.
Suite 1250
Los Angeles, CA 90025
800-718-4658
info@personalinjurylawcal.com
www.personalinjurylawcal.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Yaz Lawsuit Settlements Reach $142 Million here

News-ID: 219602 • Views: 7417

More Releases from Nadrich & Cohen LLP

Yaz, Yasmin to Get New Labels as FDA Warns of Blood Clot Risk
Nadrich & Cohen, LLP reports that Yaz and similar birth control pills are to receive updated warning labels advising patients of the risk for developing serious blood clots. Los Angeles, CA, April 10, 2012 – National law firm Nadrich & Cohen, LLP has learned that the U.S. Food and Drug Administration has ordered Bayer to produce new warning labels for several of its oral contraceptives, including Yaz, Yasmin and Beyaz.
FDA Schedules Advisory Panel Meeting to Discuss Metal Hip Safety
Nadrich & Cohen, LLP reports that the FDA has scheduled an advisory panel to discuss the safety of metal hip implants. Los Angeles, CA, March 29, 2012 – National law firm Nadrich & Cohen, LLP has learned that the U.S. Food and Drug Administration has a scheduled an advisory panel meeting to discuss the safety of metal hip implants and all-metal hip resurfacing systems. The two-day panel, which is expected
Pradaxa Side Effects Lawsuits Filed in Federal Court
Nadrich & Cohen, LLP reports that three Pradaxa side effects lawsuits have been filed in federal courts across the country. Los Angeles, CA, March 7, 2012 – National law firm Nadrich & Cohen, LLP has learned that three Pradaxa side effects lawsuits have been filed against Boehringer Ingelheim, the drug’s manufacturer. The cases were filed in federal district courts located in Tennessee, Kentucky and Louisiana and it’s believed they are the
Bayer Agrees to Settlement in 70 Yaz Side Effects Lawsuits
Nadrich & Cohen, LLP reports that Bayer has agreed to settlements with a number of plaintiffs who sued the company over Yaz side effects. Los Angeles, CA, March 5, 2012 – National law firm Nadrich & Cohen, LLP reports that Bayer Healthcare has agreed to settle approximately 70 lawsuits filed on behalf of women who claim they were seriously injured by Yaz birth control pills. The amount of the settlements has

All 5 Releases


More Releases for Yaz

Global Automotive Aftermarket Industry Forecasts by Key Players: Bridgestone, De …
Market Overview:- Global Automotive aftermarket industry is led by replacement parts accounting for over USD 350 billion in 2015. These parts are used as replacement over original auto parts after wear & tear, damage or reduction in vehicle performance. Request For Sample Copy Of This Report @ https://www.gminsights.com/request-sample/detail/1166 Top Key Players:- The key players of global Automotive Aftermarket Industry are Bridgestone Corporation, Denso Corporation,
Global Yttria Alumina Zirconia (YAZ) Market 2016-2021: Industry Size, Share, Ana …
The 'Global and Chinese Yttria Alumina Zirconia (YAZ) Market, 2016-2021 Market Research Report' is a professional and in-depth study on the current state of the global Yttria Alumina Zirconia (YAZ) industry with a focus on the Chinese market. The report provides key statistics on the market status of the Yttria Alumina Zirconia (YAZ) manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the
A slice of the Orient in Stuttgart
Fraunhofer experts help get the YAZ restaurant concept off to a successful start in Stuttgart Food, glorious food. Not only must it taste good, but the service has to be right, too. And here’s a winning recipe: Before opening the doors of its flagship restaurant in Stuttgart in September 2013, the YAZ Company put a test version through its paces – in collaboration with service engineering experts from Fraunhofer IAO. YAZ is
Yaz, Yasmin to Get New Labels as FDA Warns of Blood Clot Risk
Nadrich & Cohen, LLP reports that Yaz and similar birth control pills are to receive updated warning labels advising patients of the risk for developing serious blood clots. Los Angeles, CA, April 10, 2012 – National law firm Nadrich & Cohen, LLP has learned that the U.S. Food and Drug Administration has ordered Bayer to produce new warning labels for several of its oral contraceptives, including Yaz, Yasmin and Beyaz.
Bayer Agrees to Settlement in 70 Yaz Side Effects Lawsuits
Nadrich & Cohen, LLP reports that Bayer has agreed to settlements with a number of plaintiffs who sued the company over Yaz side effects. Los Angeles, CA, March 5, 2012 – National law firm Nadrich & Cohen, LLP reports that Bayer Healthcare has agreed to settle approximately 70 lawsuits filed on behalf of women who claim they were seriously injured by Yaz birth control pills. The amount of the settlements has
Nadrich & Cohen LLP Clarifies Statements Regarding Actos Bladder Cancer Lawsuits
Los Angeles, CA, January 24, 2012 – National law firm Nadrich & Cohen LLP would like to clarify previous statements regarding the pending Actos bladder cancer litigation. Earlier press releases included incorrect information regarding the total number of Actos lawsuits filed against the drug’s manufacturer, Takeda Pharmaceuticals. Those releases, based on media reports, estimated the number of lawsuits filed in state and federal courts nationwide in connection with Actos numbered